PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97354349 |
Filing Date: 04/08/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97354349 |
---|---|
MARK INFORMATION | |
*MARK | COMPLETE |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | COMPLETE |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | AbbVie Biotechnology Ltd |
*MAILING ADDRESS | Thistle House, 4 Burnaby Street |
*CITY | Hamilton, Pembroke |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Bermuda |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
HM11 |
PHONE | 847-937-3386 |
FAX | 847-938-2623 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Bermuda |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 041 |
*IDENTIFICATION | Providing a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology, women's health-related diseases, neurological disorders, muscle dystonias, muscle disorders, nerve disorders, headaches, hyperhidrosis, wrinkles, cerebral palsy, spasms, tremors and pain and treatments thereof |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 01/01/2013 |
FIRST USE IN COMMERCE DATE | At least as early as 01/01/2013 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-159180140142-2022040 8152839657176_._Savings_a nd_Support___QULIPTA_Comp lete.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0004.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0005.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0006.JPG | |
ORIGINAL PDF FILE | SPE0-159180140142-2022040 8152839657176_._Skyrizi_C omplete___Patient_Support ___Resources.pdf |
CONVERTED PDF FILE(S) (9 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0007.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0008.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0009.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0010.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0011.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0012.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0013.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0014.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0015.JPG | |
ORIGINAL PDF FILE | SPE0-159180140142-2022040 8152839657176_._HUMIRA_Co mplete___Patient_Resource s___Support.pdf |
CONVERTED PDF FILE(S) (6 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0016.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0017.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0018.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0019.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0020.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0021.JPG | |
SPECIMEN DESCRIPTION | Digital images of website pages of three different products showing mark in uase. |
WEBPAGE URL | http://www.qulipta.com/savings-support/qulipta-complete-savings-program |
WEBPAGE DATE OF ACCESS | 04/08/2022 |
WEBPAGE URL | http://www.skyrizi.com/skyrizi-complete/about-skyrizi-complete |
WEBPAGE DATE OF ACCESS | 04/08/2022 |
WEBPAGE URL | http://www.humira.com/humira-complete |
WEBPAGE DATE OF ACCESS | 04/08/2022 |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology, women's health-related diseases, neurological disorders, muscle dystonias, muscle disorders, nerve disorders, headaches, hyperhidrosis, wrinkles, cerebral palsy, spasms, tremors and pain and treatments via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 01/01/2013 |
FIRST USE IN COMMERCE DATE | At least as early as 01/01/2013 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-1-159180140142-20220 408152839657176_._Savings _and_Support___QULIPTA_Co mplete.pdf |
CONVERTED PDF FILE(S) (4 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0022.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0023.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0024.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0025.JPG | |
ORIGINAL PDF FILE | SPE0-1-159180140142-20220 408152839657176_._Skyrizi _Complete___Patient_Suppo rt___Resources.pdf |
CONVERTED PDF FILE(S) (9 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0026.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0027.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0028.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0029.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0030.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0031.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0032.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0033.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0034.JPG | |
ORIGINAL PDF FILE | SPE0-1-159180140142-20220 408152839657176_._HUMIRA_ Complete___Patient_Resour ces___Support.pdf |
CONVERTED PDF FILE(S) (6 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0035.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0036.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0037.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0038.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0039.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\973\543\97354349\xml1\ APP0040.JPG | |
SPECIMEN DESCRIPTION | Digital images of website page for three different sites for our products showing mark in use. |
WEBPAGE URL | http://www.qulipta.com/savings-support/qulipta-complete-savings-program |
WEBPAGE DATE OF ACCESS | 04/08/2022 |
WEBPAGE URL | http://www.skyrizi.com/skyrizi-complete/about-skyrizi-complete |
WEBPAGE DATE OF ACCESS | 04/08/2022 |
WEBPAGE URL | http://www.humira.com/humira-complete |
WEBPAGE DATE OF ACCESS | 04/08/2022 |
ATTORNEY INFORMATION | |
NAME | Matthew O. Brady |
ATTORNEY DOCKET NUMBER | ABVT70730 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | AbbVie Inc. |
INTERNAL ADDRESS | Mail code: AND-250C |
STREET | 18655 Teller Avenue |
CITY | Irvine |
STATE | California |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 92612 |
PHONE | 847-937-3386 |
FAX | 847-938-2623 |
EMAIL ADDRESS | mbrady@abbvie.com |
OTHER APPOINTED ATTORNEY | Cheryl A. Withycombe |
CORRESPONDENCE INFORMATION | |
NAME | Matthew O. Brady |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | mbrady@abbvie.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | trademarks@abbvie.com; kimberly.gleason@abbvie.com; cheryl.withycombe@abbvie.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 700 |
*TOTAL FEES PAID | 700 |
SIGNATURE INFORMATION | |
SIGNATURE | /mob/ |
SIGNATORY'S NAME | Matthew O. Brady |
SIGNATORY'S POSITION | Vice President |
SIGNATORY'S PHONE NUMBER | 714-246-4788 |
DATE SIGNED | 04/08/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97354349 |
Filing Date: 04/08/2022 |
The applicant's current Correspondence Information: |
Matthew O. Brady |
PRIMARY EMAIL FOR CORRESPONDENCE: mbrady@abbvie.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@abbvie.com; kimberly.gleason@abbvie.com; cheryl.withycombe@abbvie.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|